Aimed at verifying the occurrence of adverse events related to enteral nutrition use in patients of a public hospital in the countryside of Rio Grande do Sul. A quantitative, longitudinal and descriptive study, conducted in January-May 2012, that accompanied 46 patients admitted to the Intensive Care Unit and Medical Clinic. For evaluating the adverse events, we used quality indicators: inadvertent exit, tube obstruction and volume of infused diet.
View Article and Find Full Text PDFUnlabelled: Host genetic factors play an important role in mediating resistance to HIV-1 infection and may modify the course of infection. HLA-B alleles (Bw4 epitope; B*27 and B*57) as well as killer cell immunoglobulin-like receptors have been associated with slow progression of HIV-1 infection.
Objective: To evaluate the association between serological epitopes HLA-Bw4 and HLA-Bw6 and prognostic markers in AIDS.
Forty-nine AIDS patients, most of who were antiretroviral therapy (ARV) naive, with active tuberculosis, were treated with Rifampin 600 mg, Isoniazid 400 mg and Pirazinamide 2 g daily. They also received ARV, consisting of Efavirenz (600 mg/day) plus 2 NRTIs. All patients were prospectively followed for at least 24 months.
View Article and Find Full Text PDF